Skip to main content

Table 2 Environmental and clinical characteristics of the study population according to levels of asthma control

From: Factors associated with asthma control: MOSAR study (Multicenter Observational Study of Asthma in Rabat-Morocco)

 

All

Controlled

Partly controlled

Uncontrolled

p-value

n = 396

n = 211

n = 72

n = 113

 

Season of consultation, n(%)

    

.280

  Summer

69(17.5)

44(63.8)

10(14.5)

15(21.7)

 

  Automn

129(32.7)

62(48.1)

26(20.2)

41(31.8)

 

  Winter

155(39.3)

82(52.9)

25(16.1)

48(31.0)

 

  Spring

41(10.4)

21(51.2)

11(26.8)

9(22.0)

 

Reasons of the current visit, n(%)

    

.000*

  A follow-up visit

348(87.9)

208(59.8)

60(17.2)

80(23.0)

 

  Aggravation of asthma

48(12.1)

3(6.2)

12(25.0)

33(68.8)

 

 History of asthma, mean(±SD)

11.4(±9.7)

12(±9.9)

10(±9.5)

11(±9.5)

.331

 Family history of asthma, n(%)

    

.514

  None

226(58.2)

115(50.9)

42(18.6)

69(30.5)

 

  Yes (parents, grandparents, uncles and aunts)

162(41.8)

92(56.8)

26(16.0)

44(27.2)

 

Smoking habits, n(%)

    

.031*

  Never smoker

327(83.4)

166(50.8)

57(17.4)

104(31.8)

 

  Active smoker

35(8.9)

21(60.0)

9(25.7)

5(14.3)

 

  Ex-smoker

30(7.7)

22(73.3)

4(13.3)

4(13.3)

 

Passive smoking, n(%)

    

.881

  No

144(39.5)

77(53.3)

27(18.8)

40(27.8)

 

  Yes

221(60.5)

120(54.3)

37(16.7)

64(29.0)

 

Concomitant diseases, n(%)

    

.001*

  No

136(34.4)

89(65.4)

21(15.4)

26(19.1)

 

  Yes

259(65.6)

121(46.7)

51(19.7)

87(33.6)

 

Co-morbidities, n(%)

     

  Rhinitis

221(59.7)

109(49.3)

44(19.9)

68(30.8)

.045*

  Allergic conjunctivitis

165(44.6)

78(47.3)

34(20.6)

53(32.1)

.039*

  Gastroesophageal Reflux Disease

38(9.6)

12(31.6)

8(21.1)

18(47.4)

.011*

  Respiratory Infections

65(16.5)

13(20.0)

18(27.7)

34(52.3)

.000*

Waking during the night, n(%)

    

.000*

  No

254(65.3)

205(80.7)

18(7.1)

31(12.2)

 

  Yes

135(34.7)

0(0.0)

53(39.3)

82(60.7)

 

Number of crisis, n(%)

    

.000*

  ≤2/week

276(70.6)

208(75.4)

55(19.9)

13(4.7)

 

  > 2/week

115(29.4)

0(0.0)

16(13.9)

99(86.1)

 

Symptoms during 3 previous months

     

  Expectoration

29(7.3)

0(0.0)

7(24.1)

22(75.9)

.000*

  Wheezing

92(72.4)

0(0.0)

36(39.1)

56(60.9)

.016*

  Dyspnea

109(27.5)

0(0.0)

38(34.9)

71(65.1)

.000*

  Nocturnal coughing

69(55.2)

0(0.0)

26(37.7)

43(62.3)

.283

Allergy to, n(%)

     

  Dust

295(76.8)

153(51.9)

56(19.0)

86(29.2)

.199

  Animals

76(19.8)

29(38.2)

18(23.7)

29(38.2)

.008*

  Mold

233(60.7)

123(52.8)

41(17.6)

69(29.6)

.767

  Pollen

121(31.6)

57(47.1)

24(19.8)

40(33.1)

.157

 Smoke

20(5.1)

9(45.0)

6(30.0)

5(25.0)

.375

 Medication

40(10.1)

25(62.5)

3(7.5)

12(30.0)

.168

 Certain foods

49(14.2)

25(51.0)

6(12.2)

18(36.7)

.333

 Season variation

89(22.5)

50(56.2)

11(12.4)

28(31.5)

.260

 Other cause of crisis, n(%)

  Stressful event

8(2.0)

4(50.0)

2(25.0)

2(25.0)

.879

  Emotion

2(0.5)

0(0.0)

0(0.0)

2(100.0)

.081

  Effort

16(4.1)

6(37.5)

3(18.8)

7(43.8)

.348

Pulmonary function testing (FEV), n(%)

    

.377

  FEV < 80%

29(64.4)

16(55.2)

7(24.1)

6(20.7)

 

  FEV ≥80%

16(35.6)

6(37.5)

7(43.8)

3(18.8)

 

Adherence to treatment, n(%)

    

.488

  No

12(3.0)

6(50.0)

1(8.3)

5(41.7)

 

  Yes

384(97.0)

205(53.4)

71(18.5)

108(28.1)

 
  1. FEV Forced Expiratory Volume in one second, n number of cases, SD Standard Deviation;%: percentage
  2. Results are presented as mean ± SD or n(%) when appropriate
  3. * Significant, P < 0.05